Skip to Content

Patient Opportunity FI LMOFX

Medalist Rating as of | See Patient Funds Investment Hub
  • NAV / 1-Day Return 36.23  /  +1.74 %
  • Total Assets 1.5 Bil
  • Adj. Expense Ratio
    2.160%
  • Expense Ratio 2.160%
  • Distribution Fee Level High
  • Share Class Type No Load
  • Category Mid-Cap Blend
  • Investment Style Mid Blend
  • Min. Initial Investment
  • Status Open
  • TTM Yield
  • Turnover 40%

USD | NAV as of Jul 26, 2024 | 1-Day Return as of Jul 26, 2024, 10:17 PM GMT+0

Morningstar’s Analysis LMOFX

Will LMOFX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Still volatile after a leadership transition.

Associate Director Andrew Daniels

Andrew Daniels

Associate Director

Summary

Patient Opportunity has a new name, lead manager, and parent company, but its long-standing traits remain the same.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings LMOFX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 46.4
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Amazon.com Inc

6.36 96.6 Mil
Consumer Cyclical

Alphabet Inc Class A

5.70 86.5 Mil
Communication Services

Citigroup Inc

5.43 82.5 Mil
Financial Services

Expedia Group Inc

4.56 69.3 Mil
Consumer Cyclical

Energy Transfer LP

4.49 68.1 Mil
Energy

Meta Platforms Inc Class A

4.15 63.0 Mil
Communication Services

NVIDIA Corp

4.07 61.8 Mil
Technology

General Motors Co

3.98 60.4 Mil
Consumer Cyclical

IAC Inc Ordinary Shares - New

3.85 58.4 Mil
Communication Services

OneMain Holdings Inc

3.83 58.2 Mil
Financial Services